Gastrointestinal symptoms in children with functional abdominal pain. Other and unspecified abdominal pain
Conditions
Interventions
Intervention 1: Intervention group: People who entered the study and were diagnosed with unspecified functional abdominal pain will receive Razak Company melatonin supplements for 4 weeks from the beg
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
3 Years to 18 Years
Inclusion criteria
Inclusion criteria: Age 3 to 18 years negative tissue transglutaminase antibodies and ruling out celiac disease Definitive diagnosis of functional abdominal pain based on the Rome IV criteria, which includes functional abdominal pain with other causes (FAP-NOS).
Exclusion criteria
Exclusion criteria: Incomplete information Immunocompromised patients Uncontrolled co-morbidities (e.g. type 1 diabetes, hypothyroidism) Taking medications that affect bowel movements (laxatives, probiotics, etc.)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain relief. Timepoint: Before the start of the intervention and at the end of the intervention after 4 weeks of treatment. Method of measurement: Wong-Baker FACES Pain Rating Scale.;Gastrointestinal symptoms (diarrhea, nausea and vomiting, constipation, etc.). Timepoint: Before the start of the intervention and at the end of the intervention after 4 weeks of treatment. Method of measurement: Reported clinical symptoms. | — |
Secondary
| Measure | Time frame |
|---|---|
| Severity of disease symptoms. Timepoint: Before the intervention and the end of the intervention after 4 weeks of treatment. Method of measurement: Clinical Global Impression-Severity.;Rate of improvement in symptoms. Timepoint: Before the intervention and the end of the intervention after 4 weeks of treatment. Method of measurement: Clinical Global Impression-Improvement. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactElham Rahnemoun
Tehran University of Medical Sciences
Outcome results
None listed